AlenCiken

Recognized R&D Pioneers in Anti-Inflammatory Therapeutics

NASDAQ:ATNF   180 Life Sciences Corp.
The founding team members at 180 Life Sciences Corp. (NASDAQ: ATNF) are the recognized pioneers of research and development in anti-inflammatory therapeutics.

180 Life Sciences is a clinical-stage biotechnology company that brings together the expertise of world-renowned scientists to develop and test novel treatments for inflammation and is currently working in both preclinical and clinical studies.

finance.yahoo.com/ne...asdaq-123000501.html

免责声明

这些信息和出版物并不意味着也不构成TradingView提供或认可的金融、投资、交易或其它类型的建议或背书。请在使用条款阅读更多信息。